-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
A few days ago, Allergan (Allergan) and Soliton announced that they have reached a cooperation agreement
.
According to the agreement, Allergan Aesthetics will acquire Soliton and acquire its RESONIC™, a fast sound pulse equipment
It is a short-term non-invasive treatment to improve the appearance of cellulite
.
The acquisition of Soliton will expand and complement Allergan Aesthetics's Body Contouring Treatment portfolio including CoolSculpting Elite
Founded in April 2012, Soliton is a company that develops medical technology equipment for medical treatment and medical cosmetology
.
Soliton's novel technology platform uses non-invasive fast high-frequency sound waves to destroy the structure and connective tissue of target cells, and physically affect the fibrous membrane that causes wrinkles under the skin
According to the terms of the transaction, Allergan Aesthetics will acquire Soliton's outstanding shares at a cash price of US$22.
60 per share
.
The Soliton transaction has an enterprise value of approximately US$550 million and was approved by the boards of directors of the two companies